Thousands of Women's Lives Depend on the Improvement of Poland's Cervical Cancer Screening and Prevention Education as Well as Better Networking Strategies Amongst Cervical Cancer Facilities.

Proper targeted cancer prophylaxis reduces the incidence of cancer in all forms; this includes cancers with significant progression potential and poor prognosis. Based on the assumption that one of the risk factors of cervical cancer is the avoidance of screening tests, we analyzed the current scenario of cervical cancer (CC) screening and recommendations in Poland (country with a well-off socioeconomic status). Based on the comprehensive literature review concerning documents of guidelines and recommendations of various bodies, including national ones, data on the implementation of CC screening in Poland, and different models for medium-to-high-income countries, we proposed how the CC screening strategy could be improved.

[Mineralization of the basal ganglia as the supposed cause of poor tolerance of zuclopenthixol in a patient with long-term untreated paranoid schizophrenia].

Formations described as intracranial calcifications can appear in the course of diseases of the central nervous system, other systems and organs (e.g. endocrine), but also as a disorder of idiopathic character.

[Risk of diabetes mellitus after pregnancy complicated by gestational diabetes mellitus (GDM)].

Objectives: The aim of the study was an assessment of glucose tolerance disorders' (GTD) prevalence after pregnancy complicated by GDM.

Design: Retro- and prospective clinical study.

Material And Methods: The group of 461 women having GDM in their index pregnancies was invited to postpartum glucose metabolism assessment.

[The prevalence of gestational diabetes mellitus in Polish population].

Objective: The aim of the study was to determine the frequency of GDM in different parts of Poland and to assess whether 1 h--glucose plasma levels after 50 g glucose tolerance test (50 g OGTT) reflect the risk of GDM.

Material And Methods: A total of 5778 pregnant women were screened with 50 g OGTT between 24 and 28 weeks of gestation. All subjects whose post-challenge glucose levels exceeded 140 mg/dl had 75 g OGTT performed according to WHO criteria.